Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT02439294
Eligibility Criteria:
Inclusion Criteria:
* Provision of informed consent prior to any study specific procedures,
* Adults, men and women aged \< 90 years,
* Hospitalized in Intensive Care Units, MI confirmed by the study of the coronary arteries (coronary angiography) in acute phase (primary coronary angiography) or secondarily (ambulatory IDM IDM initially reperfused by thrombolysis),
* Myocardial infarction defined the criteria normally applied (STEMI: ST segment depression greater than 2 mm in at least 2 contiguous leads or new onset of pain and a left bundle branch block),
* The score of delayed enhancement MRI should be greater than 5 segments of 17 during the first MRI (criterion of severity of AMI),
* The subject must be affiliated to a social security scheme
Exclusion Criteria:
* Patients for whom CPAP equipment has demonstrated its usefulness regardless of cardiovascular context
* Patients sleepy (Epworth score\> 13)
* Road Truckers
* Contraindication to achieve cardiac MRI (primary endpoint):
* known and crippling claustrophobia,
* metal clips intracranial, intraocular,
* presence of an implantable defibrillator
* presence of a pacemaker
* history of injury by firearm or shrapnel balance without known projections
* hypersensitivity to gadolinium products (or history of systemic sclerosis skin) or severe renal impairment with creatinine clearance \<30 ml / min
* any other known cause of contra-indication.
* Mild infarction (rate of late enhancement MRI in less than or equal to 4 segments of 17 during the first MRI)
* Patient previously treated with CPAP prior MI or already experienced with sleep apnea syndrome.
* SAS whose central part is predominantly (\> 50%)
* General
* Inability to understand the nature and goals of the study and / or communication difficulties with the investigator
* No affiliation to a French social security recipient or not such a scheme
* Major protected by law (guardianship, curators or under judicial protection)
* deprivation of liberty by judicial or administrative decision
* Increased likelihood of non compliance to the protocol or abandonment under study
* History or presence of psychoactive substance abuse
* pregnancy, become pregnant, or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT02439294
Study Brief:
Protocol Section:
NCT02439294